Xeriant, Inc.
XERI· OTC
XERIXeriant, Inc.
Filed Sep 30, 2020 · 10-K · 92 days after period end · 0001477932-20-005677
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $136.52K |
| Net Income | — | -$4.20M | -$191.24K | -$476.98K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xeriant, Inc. · CIK 1481504 · Engraved from SEC EDGAR
ended Jun 30, 2020 · filed Sep 30, 2020 · 92 d after period end
